TFO
ANIP icon

Tarbox Family Office’s ANI Pharmaceuticals ANIP Stock Holding History

Tarbox Family Office’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-30
Closed -$1K – 1158
2020
Q1 		$1K Buy
+30
New +$1.6K ﹤0.01% 778

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
TSW
Thompson Siegel & Walmsley Richmond, Virginia $5.57B AUM 9.46% 1-Year Est. Return
ICOM
Investment Counselors of Maryland Baltimore, Maryland $4.37B AUM 76.25% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Tarbox Family Office's ANIP Position: Q2 2020 in Review

Tarbox Family Office sold out of ANI Pharmaceuticals (ANIP) in Q2 2020, closing a stake of 30 shares — an estimated $1K sold.

Tarbox Family Office first reported a position in ANIP in Q1 2020 and held it in 1 quarter. The position peaked at $1K in Q1 2020. 134 funds tracked by Wall St. Rank hold ANIP as of Q2 2020.

  • Tarbox Family Office reported no remaining ANI Pharmaceuticals position as of Q2 2020 after selling out during the quarter.
  • Tarbox Family Office sold 30 ANI Pharmaceuticals shares in Q2 2020, an estimated $1K.
  • Tarbox Family Office first reported a position in ANI Pharmaceuticals in Q1 2020 and held it in 1 quarter.
  • Tarbox Family Office's ANI Pharmaceuticals position peaked at $1K in Q1 2020.
  • 134 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2020.

Based on Tarbox Family Office's 13F filing for Q2 2020, filed 23 Jul 2020.